| Transgene Biotek Ltd | Industry : (Healthcare) | |
|---|---|---|
|
BSE Code : 526139 |
NSE Symbol : - |
P/E(TTM) : 0.00 |
|
ISIN Demat : INE773D01018 |
Div & Yield% : 0.00 |
EPS(TTM) : 0.00 |
|
Book Value(₹) : -1.21 |
Market Cap(₹Cr) : 23.94 |
Face Value(₹) : 10.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 0.05 | 0.05 | 0.05 | 0.05 | 0.08 | 0.08 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 0.05 | 0.05 | 0.05 | 0.05 | 0.08 | 0.08 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.15 | 0.00 | 0.00 | 0.00 | 0.04 | 0.04 |
| Total Income | 0.20 | 0.05 | 0.05 | 0.05 | 0.12 | 0.12 |
| Total Expenditure | 0.33 | 0.11 | 0.13 | 0.19 | 0.62 | 0.17 |
| PBIDT | -0.13 | -0.05 | -0.07 | -0.14 | -0.50 | -0.05 |
| Interest | 0.28 | 0.27 | 0.26 | 0.25 | 0.19 | 0.02 |
| PBDT | -0.41 | -0.32 | -0.34 | -0.38 | -0.69 | -0.07 |
| Depreciation | 0.05 | 0.05 | 0.05 | 0.05 | 0.02 | 0.02 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | -0.46 | -0.37 | -0.39 | -0.43 | -0.71 | -0.09 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -0.46 | -0.37 | -0.39 | -0.43 | -0.71 | -0.09 |
| EPS (Unit Curr.) | -0.06 | -0.05 | -0.05 | -0.06 | -0.09 | -0.01 |
| EPS (Adj) (Unit Curr.) | -0.06 | -0.05 | -0.05 | -0.06 | -0.09 | -0.01 |
| Calculated EPS (Unit Curr.) | -0.06 | -0.05 | -0.05 | -0.06 | -0.09 | -0.01 |
| Calculated EPS (Adj) (Unit Curr.) | -0.06 | -0.05 | -0.05 | -0.06 | -0.09 | -0.01 |
| Calculated EPS (Ann.) (Unit Curr.) | -0.24 | -0.20 | -0.21 | -0.23 | -0.38 | -0.05 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -0.24 | -0.20 | -0.21 | -0.23 | -0.38 | -0.05 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 75.77 | 75.77 | 75.77 | 75.77 | 75.77 | 75.77 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | -260.00 | -100.00 | -140.00 | -280.00 | -625.00 | -62.50 |
| PBDTM(%) | -820.00 | -640.00 | -680.00 | -760.00 | -862.50 | -87.50 |
| PATM(%) | -920.00 | -740.00 | -780.00 | -860.00 | -887.50 | -112.50 |
